Kim Hyoung Jin, Kim So Young, Lim Su Jeung, Kim Jin Young, Lee Seung Jae, Kim Hong-Jin
College of Pharmacy, Chung-Ang University, 221 Huksuk-Dong, Dongjak-Gu, Seoul 156-756, South Korea.
Protein Expr Purif. 2010 Mar;70(1):68-74. doi: 10.1016/j.pep.2009.08.005. Epub 2009 Aug 15.
The prophylactic human papillomavirus vaccine is based on recombinant L1 protein produced in yeast or insect cells. L1 is a major capsid protein that self-assembles into virus-like particles (VLP). Conventionally, several chromatography steps are required to purify it; the steps are time consuming, and they result in losses of the target protein. Ultracentrifugation using a sucrose cushions or cesium chloride density gradients, and size-exclusion chromatography, has also been routinely used for small scale purification of L1 protein. However, these methods require a great deal of time and labor, and are not suitable for industrial-scale purification. To resolve these problems, we have developed two simple one-step chromatography methods for purifying recombinant HPV16 L1 protein produced in Saccharomyces cerevisiae. Eighty percent of the contaminating protein was removed by ammonium sulfate precipitation and by precipitating contaminants prior to the chromatography step. One method uses heparin chromatography and the other, cation-exchange chromatography, and recoveries by the two methods were both about 60%, the highest recoveries of L1 protein achieved so far. We confirmed that HPV16 L1 protein purified by either method self-assembles into VLP. We anticipate that these one-step chromatography methods will reduce the time, cost and labor needed for purification of L1 protein, and facilitate the study of prophylactic HPV vaccines.
预防性人乳头瘤病毒疫苗基于在酵母或昆虫细胞中产生的重组L1蛋白。L1是一种主要的衣壳蛋白,可自行组装成病毒样颗粒(VLP)。传统上,需要几个色谱步骤来纯化它;这些步骤耗时且会导致目标蛋白损失。使用蔗糖垫层或氯化铯密度梯度进行超速离心以及尺寸排阻色谱法,也一直常规用于L1蛋白的小规模纯化。然而,这些方法需要大量时间和人力,且不适用于工业规模的纯化。为了解决这些问题,我们开发了两种简单的一步色谱法,用于纯化在酿酒酵母中产生的重组HPV16 L1蛋白。通过硫酸铵沉淀以及在色谱步骤之前沉淀污染物,可去除80%的污染蛋白。一种方法使用肝素色谱法,另一种使用阳离子交换色谱法,两种方法的回收率均约为60%,是迄今为止L1蛋白实现的最高回收率。我们证实,通过任何一种方法纯化的HPV16 L1蛋白都会自行组装成VLP。我们预计,这些一步色谱法将减少纯化L1蛋白所需的时间、成本和人力,并促进预防性HPV疫苗的研究。